Cargando…

Clinical Efficacy of Conventional Heparin Anticoagulation Combined with Apixaban in the Treatment of Patients with Cerebral Venous Thrombosis and Its Effect on Serum D-Dimer and FIB Expression

OBJECTIVE: The aim of this study was to explore the clinical efficacy of conventional heparin anticoagulation in combination with apixaban in the treatment of patients with cerebral venous thrombosis (CVT) and its influence on serum D-dimer (D-D) and fibrinogen (FIB). METHODS: One hundred and fifty-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Xiaohui, Liu, Xiaohui, Liu, Yanqing, Jiang, Lili, Zhang, Huiping, Liu, Bofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741378/ https://www.ncbi.nlm.nih.gov/pubmed/35003321 http://dx.doi.org/10.1155/2021/4979210

Ejemplares similares

Long-term Anticoagulation with Apixaban in Patients with Cerebral Venous Thrombosis
por: Bharath, Suman Preet, et al.
Publicado: (2023)

Venous Thromboembolism While on Anticoagulation With Apixaban
por: Mazahreh, Farah, et al.
Publicado: (2021)

Efficacy and risks of anticoagulation for cerebral venous thrombosis
por: Xu, Weilin, et al.
Publicado: (2018)

Development of New Deep Venous Thrombosis While on Apixaban
por: Sharma, Munish, et al.
Publicado: (2017)

Comparison of Apixaban and Low Molecular Weight Heparin in Preventing Deep Venous Thrombosis after Total Knee Arthroplasty in Older Adults
por: Jiang, Hui, et al.
Publicado: (2019)

The efficacy and safety of low-molecular-weight heparin and unfractionated heparin in the treatment of cerebral venous sinus thrombosis
por: Afshari, Daryoush, et al.
Publicado: (2015)

Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis
por: Salehi Omran, Setareh, et al.
Publicado: (2023)

Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report
por: Gonzales, Mia, et al.
Publicado: (2019)

The anticoagulants rivaroxaban and low molecular weight heparin prevent PICC-related upper extremity venous thrombosis in cancer patients
por: Lv, Shoutian, et al.
Publicado: (2019)

Diagnostic Value of D-Dimer’s Serum Level in Iranian Patients with Cerebral Venous Thrombosis
por: Hashami, Leila, et al.
Publicado: (2016)

Safety assessment of anticoagulation therapy in patients with hemorrhagic cerebral venous thrombosis
por: Ghandehari, Kavian, et al.
Publicado: (2013)

Cerebral venous sinus thrombosis in homocystinuria: Dietary intervention in conjunction with anticoagulation
por: Yap, Sufin, et al.
Publicado: (2017)

Anticoagulation delay does not affect the functional outcome of cerebral venous thrombosis
por: Ji, Kangxiang, et al.
Publicado: (2020)

The Role of Apixaban in the Treatment of Heparin-Induced Thrombocytopenia
por: Khalid, Sidra, et al.
Publicado: (2017)

Safety and Feasibility of Subcutaneous Low Molecular Weight Heparin for Cerebral Venous Sinus Thrombosis
por: Kim, Ji Seon, et al.
Publicado: (2005)

Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) Trial
por: Liu, Xianchen, et al.
Publicado: (2015)

Aftermath of Apixaban: Atypical Anticoagulation Aftereffect
por: Karki, Bhesh, et al.
Publicado: (2022)

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review
por: Bose, Gauruv, et al.
Publicado: (2021)

Low molecular weight heparin versus unfractionated heparin in the management of cerebral venous thrombosis: A systematic review and meta-analysis
por: Qureshi, Anjum, et al.
Publicado: (2017)

Apixaban/heparin/warfarin: Treatment failure: case report
Publicado: (2021)

A Rare Case of Extensive Cerebral Venous Sinus Thrombosis Complicated by Heparin-Induced Thrombocytopenia
por: Jang Khan, Noman Ahmed, et al.
Publicado: (2022)

Cerebral venous sinus thrombosis associated with SRA-negative heparin-induced thrombocytopenia: case report
por: Silva, Floyd D., et al.
Publicado: (2023)

Association of neutrophil to lymphocyte ratio and D-dimer with functional outcome in patients with cerebral venous sinus thrombosis
por: Sun, Rui, et al.
Publicado: (2023)

Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation
por: Dutta, Ajitava, et al.
Publicado: (2021)

Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
por: Smythe, Maureen A., et al.
Publicado: (2016)

Calibration and validation of the rabbit model of electrolytic‐mediated arterial thrombosis against the standard‐of‐care anticoagulant apixaban
por: Wong, Pancras C., et al.
Publicado: (2022)

D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study
por: Palareti, Gualtiero, et al.
Publicado: (2022)

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol
por: Bose, Gauruv, et al.
Publicado: (2019)

The outcomes of pregnant and postpartum patients with cerebral venous sinus thrombosis after anticoagulant therapy
por: Meng, Shi-Hui, et al.
Publicado: (2021)

Cerebral venous thrombosis
por: Moraes, Anisio Adalio de Azevedo, et al.
Publicado: (2022)

Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome
por: Van Meerhaeghe, Tess, et al.
Publicado: (2022)

Usefullness of Heparin Calibrated Anti-Xa Activity to Assess Anticoagulant Activity of Apixaban and Rivaroxaban in Emergency Patients Scheduled for Acute Interventions
por: Riahi, Nada, et al.
Publicado: (2023)

Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
Publicado: (2020)

D-Dimer Level Associates with the Incidence of Focal Neurological Deficits in Cerebral Venous Thrombosis Patients
por: Juli, Cep, et al.
Publicado: (2020)

Feasibility of anticoagulation using low molecular-weight heparin during catheter-directed thrombolysis for lower extremity deep venous thrombosis
por: Li, Yonghui, et al.
Publicado: (2021)

Impaired Dynamic Cerebral Autoregulation in Cerebral Venous Thrombosis
por: Chen, Jie, et al.
Publicado: (2020)

Clinical analysis and misdiagnosis of cerebral venous thrombosis
por: WANG, XIAOTONG, et al.
Publicado: (2012)

Author's response to Letter to the Editor: Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis.
por: Klein, David E., et al.
Publicado: (2020)

Anticoagulation treatment and prophylactic edoxaban for cerebral sinus venous thrombosis in an adolescent with acute lymphoblastic leukemia
por: Koganesawa, Masaya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ncelqs12o20150hsi58eakk4lq